ASTRID GUTIERREZ: Open Payments
NPI 1851022982 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 19 payments from 10 companies in 2025. Trend: 2023 $166 · 2024 $158 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $143 |
| Merck Sharp & Dohme LLC | 6 | $121 |
| PFIZER INC. | 3 | $53 |
| Novo Nordisk Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| QIAGEN, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VERQUVO, ZEPBOUND, ELIQUIS, Wegovy, AREXVY, MOUNJARO, ENTRESTO, GATTEX.
Industry payments across TX — which companies pay providers there.
